
Amber Enterprises board approves enabling resolution to raise up to Rs 2,500 crore
This move was disclosed in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and follows the company's earlier intimation dated July 9. The company noted that further details regarding the type and mode of securities will be shared in compliance with SEBI's November 2024 circular, once finalized.
Additionally, the Board approved the Notice of the 35th Annual General Meeting (AGM), which is scheduled to be held on Monday, August 11, 2025, at 3:00 PM IST. The AGM notice and the Annual Report for FY 2024-25 will be shared with the stock exchanges in due course.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
a day ago
- Business Upturn
Glenmark Pharma receives warning letter from US FDA for Indore facility
By Aman Shukla Published on July 12, 2025, 21:36 IST Glenmark Pharmaceuticals has received a warning letter from the United States Food and Drug Administration (US FDA) concerning its manufacturing facility in Indore, Madhya Pradesh. The regulatory action follows an inspection conducted by the US FDA between February 3 and February 14, 2025. The company clarified that the warning letter is not expected to impact the current supply chain or revenues generated from operations at the Indore site. Importantly, Glenmark stated that the US FDA observations did not include any data integrity issues. 'This warning letter will not affect the availability of our products in the market, and we remain focused on ensuring consistent supply without disruptions,' the company said in a statement. Glenmark reaffirmed its commitment to addressing all the concerns raised by the US FDA and said it is actively working with the agency to resolve the issues at the earliest. The company emphasized its adherence to Current Good Manufacturing Practices (CGMP) and maintaining high standards of quality and compliance across all facilities. This update follows Glenmark's earlier communication on May 9, 2025, regarding the Indore facility being classified as 'Official Action Indicated' (OAI) by the US FDA. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at


Business Upturn
a day ago
- Business Upturn
Hindustan Copper says U.S. copper tariff unlikely to impact business
By News Desk Published on July 12, 2025, 17:38 IST Hindustan Copper Limited (HCL) has clarified that the proposed 50% tariff on copper by the United States, effective August 1, 2025, is not expected to impact its operations. In a regulatory filing, the company stated that it mines copper ore and processes it into copper concentrate, which is sold primarily within India. As a result, the U.S. import tariff will have no material effect on HCL's business. The clarification was issued in response to recent media reports about the upcoming U.S. tariff, with HCL assuring investors there is no direct export exposure that would warrant concern. This disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ahmedabad Plane Crash News desk at


Business Upturn
a day ago
- Business Upturn
TGV SRAAC to set up additional 40 MW solar power plant at Rs 120 crore
TGV SRAAC has announced that its Board of Directors has approved the setting up of a new 40 MW solar power plant at an estimated cost of ₹120 crore. The decision was passed via circular resolution on July 12, 2025. The project will be funded through internal accruals and/or bank finance. The upcoming 40 MW solar plant is expected to be installed near TGV SRAAC's factory or at an alternate suitable location. This expansion aligns with the company's continued focus on sustainable energy and reducing its carbon footprint through clean power generation. Advertisement In the exchagne filings the copmany shared, 'We bring to your kind notice that the Board has given approval by way of Circular Resolution on 12.07 .2025 to the Company for setting up of further 40 MW Solar Power plant near to our Factory/elsewhere at a total approximate cost of Rs.120 Cr funded through internal accruals / Bank finance.' This latest move comes in addition to the company's earlier board approval for a 60 MW solar project—of which 37.90 MW has already been completed and is generating power, while the remaining 22.10 MW is under progress and advancing as planned.